24/7 Wall St. Most Overpaid CEO Of The Day: PharmaNet Development (PGDI) CEO Jeffrey P. McMullen
PharmaNet Development (PDGI), a clinical services company, lowered its 2008 forecast for the second time, projecting a loss of 25 cents to 58 cents per share on $358 million to $366 million in revenue. Investors were unusually upset and sent…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
PharmaNet Development (PDGI), a clinical services company, lowered its 2008 forecast for the second time, projecting a loss of 25 cents to 58 cents per share on $358 million to $366 million in revenue.
Investors were unusually upset and sent the stock down 52% to $10.07, a new 52-week low. The period high was $43.05.
The company’s CEO Jeffrey P. McMullen does not have to worry much.
McMullen had a base salary of $695,000 last year. He even got a raise to $740,000 for 2008. In 2007, Mullen picked up a bonus check for $886,000.
According to the PDGI proxy, Mr. McMullen’s employment agreement awards him perquisites up to the amount of $32,500. If there is change of control at the company he gets 36 months of his base pay.
That’s a very good deal for a company which has wiped out $600 million of its market cap.
Douglas A. McIntyre
Contact [email protected] for any questions or corrections.